120 Participants Needed

Yoga for Cardiovascular Disease

(SLYM II Trial)

YV
Overseen ByYuliya Vengrenyuk
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Icahn School of Medicine at Mount Sinai
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The aim of the prospective randomized single center study is to evaluate the effect of a short-term (16 weeks) yoga program on micro RNA (miRNA) expression and cardiovascular disease (CVD) risk factors in patients with CVD.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Chair Yoga, Accessible Yoga, Adaptive Yoga, Seated Yoga for cardiovascular disease?

Research shows that yoga can help reduce risk factors for heart disease, such as stress, anxiety, and depression, and improve quality of life. While yoga may not directly improve heart function, it can be a helpful addition to heart disease treatment by enhancing overall well-being.12345

Is yoga safe for people with cardiovascular disease?

Research shows that yoga is generally safe, with no significant difference in serious or nonserious adverse events compared to usual care or exercise. However, there may be more minor adverse events compared to psychological or educational interventions.16789

How does the treatment Chair Yoga differ from other treatments for cardiovascular disease?

Chair Yoga is unique because it offers a gentle, accessible form of exercise that can be done while seated, making it suitable for individuals with limited mobility or those who face barriers to traditional exercise. It focuses on gentle stretching and breathing, which can improve heart health and quality of life without the need for intense physical activity.110111213

Research Team

Annapoorna Kini, MD - Physician's ...

Annapoorna Kini, MD

Principal Investigator

MOUNT SINAI HOSPITAL

Eligibility Criteria

Adults aged 18-80 with metabolic syndrome and cardiovascular disease who have undergone certain heart procedures or have risk factors like high blood pressure can join. They must be able to do yoga and follow the study plan. People with severe heart failure, arrhythmias, implants, autoimmune diseases, recent transplants or pregnancy, severe lung disease, liver issues or heavy alcohol use cannot participate.

Inclusion Criteria

I had a heart procedure at Mount Sinai or have heart disease risk factors.
I am between 18 and 80 years old.
I have been diagnosed with metabolic syndrome, having at least three of the specified conditions.
See 1 more

Exclusion Criteria

I have heart issues or metal implants in my body.
I do not drink more than the recommended amount of alcohol weekly.
I have severe breathing problems or a serious illness.
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants practice yoga poses in a chair for 30 minutes at least 3 days a week for 16 weeks or follow standard of care treatment

16 weeks
Weekly yoga sessions (self-guided)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with blood samples collected for miRNA expression profile

22 months
Follow-up visit at 16 weeks and end of study at 22 months

Treatment Details

Interventions

  • Chair Yoga
Trial OverviewThe trial is testing if a 16-week chair yoga program can change micro RNA expression linked to heart disease and improve related health markers in patients with cardiovascular conditions.
Participant Groups
2Treatment groups
Active Control
Group I: YogaActive Control1 Intervention
Patients randomized to Yoga arm will practice chair yoga for 30 minutes at least three days a week for 16 weeks
Group II: Standard of CareActive Control1 Intervention
Control group patients will follow standard of care (SOC) treatment.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Icahn School of Medicine at Mount Sinai

Lead Sponsor

Trials
933
Recruited
579,000+

Findings from Research

A meta-analysis of 44 randomized controlled trials involving 3168 participants found that yoga significantly reduces key cardiovascular risk factors, including blood pressure, heart rate, waist circumference, and cholesterol levels, compared to usual care.
Despite some methodological concerns, the results suggest that yoga can be an effective complementary intervention for improving cardiovascular health in both the general population and high-risk groups.
Effects of yoga on cardiovascular disease risk factors: a systematic review and meta-analysis.Cramer, H., Lauche, R., Haller, H., et al.[2022]
A systematic review of 7 randomized controlled trials involving 624 patients found very low evidence that yoga has no effect on mortality in patients with coronary heart disease, heart failure, and cardiac dysrhythmias, but it may reduce angina episodes and improve exercise capacity.
Despite the weak evidence for its effectiveness, yoga was reported to be safe, with no adverse events noted in the studies, leading to weak recommendations for its use as an ancillary intervention in heart disease.
A systematic review of yoga for heart disease.Cramer, H., Lauche, R., Haller, H., et al.[2022]
A new yoga program tailored for post-myocardial infarction patients with left ventricular dysfunction was developed, incorporating exercises, breathing techniques, and meditation, and validated by experts in health and yoga.
The module showed good reliability and consistency, with a recommendation for 1 hour of supervised training for one month, suggesting it could be a beneficial addition to cardiac rehabilitation, pending further clinical trials.
Development of a yoga module targeting cardiovascular health for patients with post-myocardial left ventricular dysfunction in India.Sharma, S., Pailoor, S., Choudhary Ram, N., et al.[2019]

References

Effects of yoga on cardiovascular disease risk factors: a systematic review and meta-analysis. [2022]
A systematic review of yoga for heart disease. [2022]
Development of a yoga module targeting cardiovascular health for patients with post-myocardial left ventricular dysfunction in India. [2019]
Appropriateness and acceptability of a Tele-Yoga intervention for people with heart failure and chronic obstructive pulmonary disease: qualitative findings from a controlled pilot study. [2022]
Integrated Yoga Practice in Cardiac Rehabilitation Program: A Randomized Control Trial. [2021]
The Safety of Yoga: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [2018]
Exposure to Adverse Events and Associations with Stress Levels and the Practice of Yoga: Survey Findings from a Population-Based Study of Diverse Emerging Young Adults. [2020]
A large-scale survey of adverse events experienced in yoga classes. [2022]
Health-related benefits and adverse events associated with yoga classes among participants that are healthy, in poor health, or with chronic diseases. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Getting Into Light Exercise (GENTLE-HF) for Patients With Heart Failure: the Design and Methodology of a Live-Video Group Exercise Study. [2023]
Effects of Yoga in Patients with Chronic Heart Failure: A Meta-Analysis. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
Effects of Hatha Yoga on Cardiac Hemodynamic Parameters and Physical Capacity in Cardiac Rehabilitation Patients. [2021]
Enhancing the appeal of cardiac rehabilitation for women: development and pilot testing of a women-only yoga cardiac rehabilitation programme. [2022]